Azaserine inhibits?
**Core Concept:** Azaserine is an alkylating agent primarily used as a carcinogen in food processing. It is an analogue of the natural amino acid, L-asparagine, and interferes with the normal biological functions of L-asparagine, an essential amino acid involved in various cellular processes.
**Why the Correct Answer is Right:** Azaserine exerts its cytotoxic effects by alkylating DNA and proteins, leading to genetic mutations, cell death, and tissue damage. In this case, it specifically inhibits the enzyme L-asparagine synthetase (AS), which plays a crucial role in synthesizing L-asparagine from L-glutamine and ATP. This inhibition results in a decrease in intracellular L-asparagine levels, causing cellular dysfunction and ultimately leading to cancer development.
**Why Each Wrong Option is Incorrect:**
A. Option A (ASP synthase): Azaserine does not inhibit ASP synthase, which is responsible for synthesizing L-aspartate from L-glutamate and ATP. ASP synthase is unrelated to the action of azaserine as a carcinogen.
B. Option B (ASP transaminase): Azaserine does not inhibit ASP transaminase, an enzyme involved in the transamination of L-aspartate and Ξ±-ketoglutarate to form L-glutamate and Ξ±-ketoglutarate. ASP transaminase is unrelated to the carcinogenic action of azaserine.
C. Option C (Glutamine synthetase): Azaserine does not inhibit glutamine synthetase, an enzyme responsible for synthesizing L-glutamine from L-glutamate and ATP. Glutamine synthetase is not involved in the carcinogenic action of azaserine.
D. Option D (L-asparagine synthetase): Azaserine does not inhibit L-asparagine synthetase, which is responsible for synthesizing L-asparagine from L-glutamine and ATP. L-asparagine synthetase is unrelated to the carcinogenic action of azaserine.
**Clinical Pearl:** Azaserine, by inhibiting L-asparagine synthetase, results in a deficiency of L-asparagine in the cell, leading to impaired cell growth, proliferation, and ultimately cancer development. This can be considered as a molecular basis for the carcinogenic action of azaserine.